FEMARA - LETRAZOLE

Product Details:

Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Product Description

FEMARA^Ã‚Â® is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

FEMARA^Ã‚Â® is also indicated for:

Extended adjuvant treatment of hormone-dependent early breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 years.

First-line treatment in postmenopausal women with hormone-dependent advanced breast cancer.

Advanced breast cancer in women with natural or artificially induced postmenopausal status after relapse or disease progression, who have previously been treated with anti-estrogens.